BioSpace News Archive

FDA

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis

DURECT Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to larsucosterol for the treatment of patients with severe alcohol-associated hepatitis (AH).

May 21, 2024
·
9 min read
Pharm Country

Avantor® to Participate in Bernstein’s 40th Annual Strategic Decisions Conference

Avantor, Inc. announced that Michael Stubblefield , President and CEO, will be participating in a fireside chat at Bernstein’s 40th Annual Strategic Decisions Conference in New York.

May 21, 2024
·
1 min read
Pharm Country

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Daiichi Sankyo (TSE: 4568) will present new clinical research across its oncology portfolio with more than 45 abstracts in multiple cancers at the 2024 American Society of Clinical Oncology Scientific Program (#ASCO24).

May 21, 2024
·
9 min read
CDR-Life to Present at 6th Annual Cell Engager Summit

CDR-Life Inc. today announced that Chief Medical Officer Swethajit Biswas, MD, FRCP, will co-lead a seminar at the 6th Annual Cell Engager Summit, occurring May 21-23 in Boston.

May 21, 2024
·
2 min read
Business

Inspirna Announces Appointment of Karim Benhadji, M.D., as Chief Medical Officer and Retirement of Robert Wasserman, M.D.

Inspirna, Inc. announced today the appointment of Karim Benhadji, M.D., as Chief Medical Officer, effective May 1, 2024.

May 21, 2024
·
4 min read
Business

Pristine Surgical Announces the Addition of Christopher Cleary to its Board of Directors

Pristine Surgical today announced the addition of Christopher Cleary to its Board of Directors.

May 21, 2024
·
2 min read
Biotech Beach

Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium

Lineage Cell Therapeutics, Inc. today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium (“2nd SCIIS”).

May 21, 2024
·
7 min read
BioCapital

Incyte to Present at Upcoming Investor Conference - May 21, 2024

Incyte (Nasdaq:INCY) announced today that it will present at the Goldman Sachs 45 th Annual Global Healthcare Conference on Monday, June 10, 2024 at 8:00 a.m. (EDT) in Miami.

May 21, 2024
·
1 min read
Business

Alto Neuroscience Appoints Michael Hanley as Chief Operating Officer

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the expansion of the Company’s leadership team with the addition of industry veteran Michael Hanley as chief operating officer (COO).

May 21, 2024
·
3 min read
Business

Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%

Sunshine Biopharma, Inc. today announced that it has filed its 2024 first quarter report with the Securities and Exchange Commission.

May 21, 2024
·
3 min read